A Study of Nipocalimab in Healthy Male and Female Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

May 26, 2022

Study Completion Date

May 26, 2022

Conditions

Healthy

Interventions

DRUG

Nipocalimab

Participants will receive IV infusion or SC injection of nipocalimab.

OTHER

Placebo

Participants will receive IV infusion or SC injection of placebo.

Trial Locations (1)

PRA Health Sciences, Groningen

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY